The patients who could most benefit from GLP-1s for obesity and diabetes among low-income, structurally disadvantaged groups in whom diet-related diseases are concentrated often cant get access to them
Eligible seniors can get GLP-1s for $50 a month for weight loss alone The program will cover Foundayo, Zepbound and Wegovy
Primary Care Practitioners/Specialists (e.g., family physicians, nurse practitioners, gastroenterologists, endocrinologists, bariatric specialists, surgeons, endoscopists, dentists) Share the risk of aspiration associated with delayed gastric emptying and provide information about fasting and holding of the medication for all patients who are taking GLP-1 receptor agonists and undergoing procedures or imaging for which anesthesia is required
This overview helps patients researching weight loss medications in 2026 , GLP-1 pills , and obesity treatment options understand what is available now and what may be coming next
Curr Gastroenterol Rep 27 , 49 (2025)
Although ample clinical trials and meta-analyses have been conducted to highlight these limits separately, more work is needed to narrate all these metabolic parameters under one umbrella
